CURRENT STUDIES

About This Study

This clinical trial evaluated an investigational injectable treatment designed to help reduce immune-driven hair loss and support scalp hair regrowth in adults with alopecia areata.

Who This Study May Be For

• Adults with alopecia areata affecting the scalp
• Individuals with significant scalp hair loss
• Ongoing or recurrent hair loss without recent regrowth

Study Snapshot

• Treatment Type: Injectable or oral therapy (varies by study)
• Study Duration: Approximately 12 months
• Cost: No cost for study-related care
• Compensation: Available for time and travel (varies by study)

About This Study

This clinical trial is evaluating investigational injectable and oral treatments designed to help improve symptoms and disease control in adults with moderate to severe atopic dermatitis who have not found adequate relief with previous therapies.

Who This Study May Be For

• Adults 18+ with moderate to severe atopic dermatitis (eczema)
• Symptoms present for 6 months or longer
• Inadequate response to previous topical or systemic treatments
• Additional eligibility criteria apply

(Pregnancy and breastfeeding criteria are reviewed during screening.)

Study Snapshot

• Treatment Type: Injectable or oral therapy
• Study Duration: Approximately 10–12 months
• Cost: No cost for study-related care
• Compensation: Available for time and travel (varies by study)
• Scheduling: Flexible scheduling available at our Canton and Mayfield Heights locations

About This Study

This clinical trial is evaluating investigational treatment options designed to help reduce painful lesions and inflammation in adolescents and adults with hidradenitis suppurativa whose symptoms have not responded adequately to previous therapies. The options include injectable, oral, and topical treatments.

Who This Study May Be For

• Adolescents and adults with hidradenitis suppurativa
• Multiple active HS lesions, including painful or draining areas
• Symptoms present for 6 months or longer
• Inadequate response to prescription treatments
• Additional eligibility criteria apply

(Pregnancy and breastfeeding criteria are reviewed during screening.)

Study Snapshot

• Treatment Type: Topical, oral, or injectable therapies (study-specific)
• Dosing Schedule: Study-specific
• Cost: No cost for study-related care
• Compensation: Available for time and travel (varies by study)
• Scheduling: Flexible scheduling available at our Canton and Mayfield Heights locations

About This Study

This clinical trial is evaluating investigational treatments designed to reduce pustules, flare-ups, and overall symptom severity in adults with palmoplantar pustulosis, with the goal of improving long-term disease control and quality of life. Currently testing a topical medication.

Who This Study May Be For

• Adults 18+ with a confirmed diagnosis of palmoplantar pustulosis
• Active pustules affecting the palms of the hands and/or soles of the feet
• Symptoms present for several months or longer
• Additional eligibility criteria apply

(Pregnancy and breastfeeding criteria are reviewed during screening.)

Study Snapshot

• Treatment Type: Topical medication
• Study Duration: Approximately 5 months
• Cost: No cost for study-related care
• Compensation: Available for time and travel (varies by study)
• Scheduling: Flexible scheduling available at our Mayfield Heights location

About This Study

This clinical trial is evaluating an FDA-approved oral treatment and a new oral medication designed to help reduce inflammation and plaque severity in adolescents with moderate to severe plaque psoriasis who have not responded adequately to topical therapies.

Who This Study May Be For

• Adolescents ages 12–17 with a confirmed diagnosis of plaque psoriasis
• Moderate to severe plaque psoriasis
• Ability to take oral medication
• Additional eligibility criteria apply

(Pregnancy, vaccination, and other medical requirements are reviewed during screening.)

Study Snapshot

• Treatment Type: Oral tablet
• Dosing Schedule: Once daily
• Study Duration: Treatment available for at least 1 year, with the option for extended participation
• Cost: No cost for study-related care
• Compensation: Available for time and travel (varies by study)
• Scheduling: Flexible scheduling available at our Canton and Mayfield Heights locations

About This Study

This clinical trial is evaluating two FDA-approved treatments designed to help reduce inflammation and improve plaque severity in adults with moderate to severe plaque psoriasis whose symptoms have not responded adequately to topical therapies.

Who This Study May Be For

• Adults aged 40 years and older with a confirmed diagnosis of plaque psoriasis
• Moderate to severe plaque psoriasis
• History of one or more cardiovascular risk factors
• Ability to take oral medication or receive injectable treatment
• Additional eligibility criteria apply

(Pregnancy and other medical requirements are reviewed during screening.)

Study Snapshot

• Treatment Type: Oral or injectable therapy (study-specific)
• Dosing Schedule: Study-specific
• Cost: No cost for study-related care
• Compensation: Available for travel (varies by study)
• Scheduling: Flexible scheduling available
• Locations: Canton and Mayfield Heights

About This Study

This clinical trial is evaluating an investigational oral treatment designed to help reduce nodules and severe itching in adults with prurigo nodularis whose symptoms had not responded well to topical therapies.

Who This Study May Be For

• Adults with a confirmed diagnosis of prurigo nodularis
• Multiple nodules affecting both sides of the body
• Persistent, severe itching
• Symptoms not adequately controlled with prescription topical treatments

Study Snapshot

• Treatment Type: Oral treatment
• Dosing Schedule: Every 4 weeks (study-specific)
• Cost: No cost for study-related care
• Compensation: Available for time and travel (varies by study)

About This Study

This clinical trial evaluated an investigational injectable treatment designed to help reduce hives and itching in adults with chronic urticaria that had not responded well to standard antihistamine therapy.

Who This Study May Be For

• Adults 18+ with chronic spontaneous urticaria (CSU)
• Symptoms lasting 6 months or longer
• Ongoing hives and itching despite treatment with antihistamines

Study Snapshot

• Treatment Type: Injectable therapy
• Cost: No cost for study-related care
• Compensation: Available for time and travel (varies by study)

About This Study

This clinical trial is evaluating an investigational medication given by IV infusion to see whether it will bring color back to depigmented skin in patients with non-segmental vitiligo who have not found previous treatments to be successful.

Who This Study May Be For

• Adults aged 18-65 with moderate to severe non-segmental vitiligo (must involve face and body)
• Diagnosis of non-segmental vitiligo for at least 3 months
• Inadequate response to previous topical therapies, phototherapy, or oral therapies
• Additional eligibility criteria apply

Study Snapshot

• Treatment Type: IV infusion
• Study Duration: Approximately 42 weeks
• Cost: No cost for study-related care
• Compensation: Available
• Scheduling: Flexible scheduling available
• Location: Mayfield Heights